Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1988 April; 81(4): 214–216.
PMCID: PMC1291543

Specific therapy in severe fetal intrauterine growth retardation: failure of prostacyclin.


Two case histories of severe, early onset intrauterine growth retardation are presented. Intravenous prostacyclin was administered in an attempt to promote fetal growth and thus prolong the pregnancy, but was unsuccessful and resulted in intrauterine death in each case. The possible reasons for the failure of this treatment and alternative therapeutic options are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (826K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol. 1977 Sep;84(9):656–663. [PubMed]
  • Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986 Oct;93(10):1049–1059. [PubMed]
  • Ylikorkala O, Mäkilä UM. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obstet Gynecol. 1985 Jun 1;152(3):318–329. [PubMed]
  • Goodman RP, Killam AP, Brash AR, Branch RA. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol. 1982 Apr 1;142(7):817–822. [PubMed]
  • Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati MB, et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins. 1980 Jul;20(1):105–110. [PubMed]
  • Carreras LO, Vermylen J, Spitz B, Van Assche A. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol. 1981 Sep;88(9):890–894. [PubMed]
  • Wallenburg HC, Rotmans N. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet Gynecol. 1982 Nov 1;144(5):523–528. [PubMed]
  • Pickles H, O'Grady J. Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol. 1982 Aug;14(2):177–185. [PMC free article] [PubMed]
  • Ansell D, Belch JJ, Forbes CD. Depression and prostacyclin infusion. Lancet. 1986 Aug 30;2(8505):509–509. [PubMed]
  • Pearce JM. Uteroplacental and fetal blood flow. Baillieres Clin Obstet Gynaecol. 1987 Mar;1(1):157–184. [PubMed]
  • Hackett GA, Campbell S, Gamsu H, Cohen-Overbeek T, Pearce JM. Doppler studies in the growth retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity. Br Med J (Clin Res Ed) 1987 Jan 3;294(6563):13–16. [PMC free article] [PubMed]
  • Naeye RL. Maternal floor infarction. Hum Pathol. 1985 Aug;16(8):823–828. [PubMed]
  • Lewis PJ, Shepherd GL, Ritter J, Chan SM, Bolton PJ, Jogee M, Myatt L, Elder MG. Prostacyclin and pre-eclampsia. Lancet. 1981 Mar 7;1(8219):559–559. [PubMed]
  • Elder MG, Myatt L. First use of nafazatrom, a new antithrombotic drug, in pregnancy. Lancet. 1984 Jun 16;1(8390):1350–1350. [PubMed]
  • Vermylen J, Chamone DA, Verstraete M. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound. Lancet. 1979 Mar 10;1(8115):518–520. [PubMed]
  • Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985 Apr 13;1(8433):840–842. [PubMed]
  • Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. [PubMed]
  • Moncada S, Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet. 1978 Jun 17;1(8077):1286–1289. [PubMed]
  • Greer IA, Walker JJ, Calder AA, Forbes CD. Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis. Lancet. 1985 Feb 9;1(8424):351–352. [PubMed]
  • Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol. 1979 Dec 15;135(8):1086–1103. [PubMed]
  • Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol. 1986 Nov;68(5):649–653. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press